CY1119322T1 - Συνθεση για ελεγχο και βελτιωση της θηλυκης και αρσενικης γαμετογενεσης - Google Patents

Συνθεση για ελεγχο και βελτιωση της θηλυκης και αρσενικης γαμετογενεσης

Info

Publication number
CY1119322T1
CY1119322T1 CY20171100644T CY171100644T CY1119322T1 CY 1119322 T1 CY1119322 T1 CY 1119322T1 CY 20171100644 T CY20171100644 T CY 20171100644T CY 171100644 T CY171100644 T CY 171100644T CY 1119322 T1 CY1119322 T1 CY 1119322T1
Authority
CY
Cyprus
Prior art keywords
female
composition
control
treatment
improve
Prior art date
Application number
CY20171100644T
Other languages
English (en)
Inventor
Vittorio Unfer
Original Assignee
Lo. Li. Pharma S.R.L.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lo. Li. Pharma S.R.L. filed Critical Lo. Li. Pharma S.R.L.
Publication of CY1119322T1 publication Critical patent/CY1119322T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Μία σύνθεση που περιλαμβάνει μονοϊνοσιτόλη, μελατονίνη και προαιρετικά φυλλικό οξύ για τον έλεγχο της ποιότητας των γαμετών (ωοκυττάρων και σπερματοζωαρίων), προωθώντας τους φυσιολογικούς ρυθμούς παραγωγής FSH και LH και τη δράση αυτών στο επίπεδο του στόχου (ωοθήκη και όρχις), μέσω της χορήγησης της σύνθεσης σε μία τέτοια ποσότητα που να παρέχει 1 έως 4 g/ημέρα μονοϊνοσιτόλης, 1 έως 5 mg/ημέρα μελατονίνης και, προαιρετικά, 200 έως 800 μg φυλλικού οξέος.
CY20171100644T 2009-05-19 2017-06-20 Συνθεση για ελεγχο και βελτιωση της θηλυκης και αρσενικης γαμετογενεσης CY1119322T1 (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI2009A000875A IT1394926B1 (it) 2009-05-19 2009-05-19 Composizione per il controllo ed il miglioramento della gametogenesi femminile e maschile.

Publications (1)

Publication Number Publication Date
CY1119322T1 true CY1119322T1 (el) 2018-02-14

Family

ID=41571625

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20171100644T CY1119322T1 (el) 2009-05-19 2017-06-20 Συνθεση για ελεγχο και βελτιωση της θηλυκης και αρσενικης γαμετογενεσης

Country Status (11)

Country Link
EP (1) EP2253228B1 (el)
CY (1) CY1119322T1 (el)
DK (1) DK2253228T3 (el)
ES (1) ES2628709T3 (el)
HR (1) HRP20170924T1 (el)
HU (1) HUE034809T2 (el)
IT (1) IT1394926B1 (el)
LT (1) LT2253228T (el)
PL (1) PL2253228T3 (el)
PT (1) PT2253228T (el)
SI (1) SI2253228T1 (el)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20110300A1 (it) * 2011-06-14 2012-12-15 Lo Li Pharma Srl Composizione comprendente inositolo e metilcellulosa al fine di rendere i principi attivi disponibili nell'organismo per un periodo prolungato e senza variazioni nel tempo

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6964969B2 (en) * 2001-04-19 2005-11-15 Mccleary Edward Larry Composition and method for treating impaired or deteriorating neurological function
ITRM20070341A1 (it) * 2007-06-20 2008-12-21 Lo Li Pharma Srl Formulazione integrativa inofolic finalizzata al controllo dell'induzione dell'ovulazione in programmi di procreazione medicalmente assistita
US20090017143A1 (en) * 2007-07-10 2009-01-15 Doug Krotzer Composition for treatment of alcoholism

Also Published As

Publication number Publication date
EP2253228A3 (en) 2011-09-28
DK2253228T3 (en) 2017-06-19
HUE034809T2 (en) 2018-02-28
IT1394926B1 (it) 2012-07-27
PL2253228T3 (pl) 2017-11-30
SI2253228T1 (sl) 2020-02-28
LT2253228T (lt) 2017-07-10
ES2628709T3 (es) 2017-08-03
HRP20170924T1 (hr) 2017-09-22
PT2253228T (pt) 2017-07-04
EP2253228A2 (en) 2010-11-24
EP2253228B1 (en) 2017-03-22
ITMI20090875A1 (it) 2010-11-20

Similar Documents

Publication Publication Date Title
MX2021014509A (es) Composiciones farmaceuticas que comprenden meloxicam.
CR20210061A (es) Composiciones farmacéuticas que comprenden meloxicam
TN2017000424A1 (en) Novel 4-methoxy pyrrole derivatives or salts thereof and pharmaceutical composition comprising the same
CY1116698T1 (el) Συνθεση περιεχοντας υπερ-μικρονοποιημενο παλμιτοϋλ-αιθανολαμιδιο
EA201001135A1 (ru) Интратекальное лечение невропатической боли агонистами ar
CR20120493A (es) Forma farmacéutica parenteral, que libera inhibidores de aromatasa y gestágenos para el tratamiento de endometriosis
TN2010000167A1 (en) Organic compounds
UA105229C2 (uk) Фармацевтичний склад
MX2013008851A (es) Composiciones y metodos para el tratamiento de inflamacion cronica y enfermedades inflamatorias.
UY32923A (es) Compuestos policíclicos como antagonistas del receptor de ácido lisofosfatídico
UA118380C2 (uk) Заміщені сполуки дигідроізохінолінону
CY1123372T1 (el) Απο toy στοματος φαρμακευτικη συνθεση
MX337597B (es) Analogos de acido epoxieicosatrienoico y metodos para fabricar y usar los mismos.
MX2015016425A (es) Derivados de pirazolo-pirrolidin-4-ona y su uso en el tratamiento de enfermedades.
UA113962C2 (xx) Фармацевтична композиція, яка містить апоморфін як активний інгредієнт
PH12014500079A1 (en) 6-substituted phenoxychroman carboxylic acid derivatives
CY1119322T1 (el) Συνθεση για ελεγχο και βελτιωση της θηλυκης και αρσενικης γαμετογενεσης
UA102390C2 (ru) Производные (пирразолилкарбонил)имидазолидинона, предназначенные для лечения ретровирусных заболеваний
MX2015012600A (es) Compuestos de tetrahidroisoquinolina-2-il-(quinazolina-4-il) metanona como inhibidores del crecimiento de células cancerígenas.
RU2011114755A (ru) Способ снижения кадмия в теле цыплят-бройлеров
MX2012004282A (es) Composiciones farmaceuticas.
UA110933C2 (uk) Композиція для лікування есенціальної тромбоцитемії
PH12015502657B1 (en) Interactions of betanodaviruses in infection
MX2011008069A (es) Uso de inhibidores de topoisomerasa i para tratar el cancer.
UA33293U (ru) Способ лечения хронического эндометрита